Point72 Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.8M Sell
964,953
-2,097,564
-68% -$31.2M 0.02% 1095
2026
Q2
$39.8M Sell
3,062,517
-119,312
-4% -$1.36M 0.04% 526
2026
Q1
$36.2M Buy
3,181,829
+356,330
+13% +$3.86M 0.05% 516
2025
Q4
$36.3M Buy
2,825,499
+266,697
+10% +$3.29M 0.04% 557
2025
Q3
$28.6M Buy
2,558,802
+609,906
+31% +$5.89M 0.05% 421
2025
Q2
$19.3M Buy
1,948,896
+1,020,239
+110% +$10M 0.04% 515
2025
Q1
$8.72M Buy
+928,657
New +$9.8M 0.02% 734
2024
Q2
– Sell
-360,442
Closed -$2.12M – 1837
2024
Q1
$2.12M Buy
360,442
+358,342
+17,064% +$2.13M 0.01% 1249
2023
Q4
$16.5K Sell
2,100
-323,541
-99% -$2.24M ﹤0.01% 2049
2023
Q3
$2.38M Sell
325,641
-110,313
-25% -$918K 0.01% 1096
2023
Q2
$4.55M Buy
435,954
+321,454
+281% +$3.09M 0.01% 847
2023
Q1
$1.18M Sell
114,500
-25,254
-18% -$323K ﹤0.01% 1075
2022
Q4
$1.92M Sell
139,754
-517,346
-79% -$7.2M 0.01% 938
2022
Q3
$13.4M Sell
657,100
-270,103
-29% -$5.93M 0.05% 429
2022
Q2
$17.9M Sell
927,203
-218,067
-19% -$4.47M 0.08% 334
2022
Q1
$24.7M Buy
1,145,270
+366,916
+47% +$8.33M 0.1% 279
2021
Q4
$21.5M Buy
778,354
+420,822
+118% +$11.6M 0.09% 320
2021
Q3
$9.27M Sell
357,532
-359,704
-50% -$9.6M 0.04% 507
2021
Q2
$19.5M Buy
717,236
+286,427
+66% +$6.99M 0.09% 289
2021
Q1
$10.1M Buy
430,809
+64,920
+18% +$1.31M 0.05% 422
2020
Q4
$5.61M Buy
+365,889
New +$4.64M 0.03% 564
2014
Q3
– Sell
-41,300
Closed -$674K – 640
2014
Q2
$674K Buy
+41,300
New +$598K ﹤0.01% 627

Other funds holding ANGO

Point72 Asset Management's ANGO Position: Q3 2026 in Review

Point72 Asset Management reduced its AngioDynamics (ANGO) stake by 68% in Q3 2026, selling an estimated $31.2M and leaving 964,953 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #1095.

Point72 Asset Management first reported a position in ANGO in Q2 2014 and has held it in 22 quarters since. The position peaked at $39.8M in Q2 2026. 167 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Point72 Asset Management held 964,953 shares of AngioDynamics worth $14.8M as of Q3 2026.
  • Point72 Asset Management sold 2,097,564 AngioDynamics shares in Q3 2026, an estimated $31.2M.
  • AngioDynamics made up 0.02% of Point72 Asset Management's portfolio in Q3 2026, its #1095 holding.
  • Point72 Asset Management first reported a position in AngioDynamics in Q2 2014 and has held it in 22 quarters since.
  • Point72 Asset Management's AngioDynamics position peaked at $39.8M in Q2 2026.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.